Profile
Lynn E.
Bayless served as the Director of Regulatory Affairs at Voyager Therapeutics, Inc. from 2015 to 2018.
Following that, she held the position of Senior Director of Regulatory Affairs at Nightstar Therapeutics Ltd.
from 2018 to 2020.
Currently, she is the Head of Regulatory Affairs at Mustang Bio, Inc. starting from 2020.
Ms. Bayless completed her graduate degree at Massachusetts College of Pharmacy & Health Science and her undergraduate degree at Quinnipiac University.
Former positions of Lynn E. Bayless
| Companies | Position | End |
|---|---|---|
| MUSTANG BIO, INC. | General Counsel | 2024-03-31 |
| NIGHTSTAR THERAPEUTICS PLC | General Counsel | 2020-01-31 |
| VOYAGER THERAPEUTICS, INC. | General Counsel | 2018-09-30 |
Training of Lynn E. Bayless
| Massachusetts College of Pharmacy & Health Science | Graduate Degree |
| Quinnipiac University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MUSTANG BIO, INC. | Health Technology |
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nightstar Therapeutics Ltd. is a clinical-stage gene therapy. It engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded by Robert MacLaren, Miguel Seabra and Matthew During in 2014 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Lynn E. Bayless
